Industry: Pharmaceuticals, Biotechnology
Founded in 2004, Solstice Neurosciences, Inc. is a biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty products. Solstice’s first product, Myobloc® (Botulinum Toxin Type B) Injectable Solution 5,000U/mL, represents the only botulinum toxin type B currently available to physicians and patients worldwide. MYOBLOC is sold in the United States and approved in Canada. It is also sold and distributed in Europe as NeuroBloc®. MYOBLOC is indicated for the treatment of patients with cervical dystonia (CD) to reduce the severity of abnormal head position and pain associated with CD. ( www.solsticeneuro.com )
Solstice Neurosciences , Inc.
40 General Warren Blvd. Suite 160
Malvern, Pennsylvania 19355
USA
Tel: (650) 243-4400
Fax: (650) 243-4475